JNJ vs PFE
Compare dividend stocks
Pfizer, Inc. (PFE) provides a 6.87% dividend yield, notably higher than Johnson & Johnson's (JNJ) 2.12%. JNJ, however, boasts stronger dividend growth with a 29-year streak and a "safe" dividend rating, supported by a lower payout. In contrast, PFE presents a more favorable valuation with a lower P/E and a "fair" margin of safety, differing from JNJ's "expensive" status.
Key differences
Yield
5.81%
JNJ 2.10%
CAGR 5y
+5.2%
PFE +3.6%
Safety
Watch
PFE At risk
Dividend score
JNJ 4/10
PFE 4/10
Price
Today
Dividend/share
Current yield A stock's annual dividend divided by today's share price — what a new buyer would earn right now. Learn more →
Growth (TTM)
CAGR 3y
5-year dividend CAGR The compound annual growth rate of a company's dividend over the last five full years — the steady yearly pace at which the payout has grown, smoothing out one-off jumps. Learn more →
Dividend growth streak The number of consecutive years a company has raised its dividend. A long streak signals reliability; 25+ years earns the "dividend aristocrat" label. Learn more →
Dividend status
Dividend doubling time Roughly how many years until the dividend doubles if it keeps growing at its recent rate, using the Rule of 72 (72 ÷ the growth rate as a percentage). A quick feel for how fast your income compounds — a 6% raiser doubles its payout in about 12 years. Learn more →
Dividend score
Safety
Quantic · Free
Unlock the full valuation comparison
Chowder number, fair value and Dividend Yield Theory for every stock — plus track them in your portfolio.
Need more? Pro adds portfolios, options income tracking & more AI. See Pro →